PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price surge 7.20% in after-hours trading on Wednesday. This significant uptick follows the company's successful debut on the Nasdaq stock exchange earlier in the day.

The company priced its initial public offering (IPO) at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs to raise approximately $20 million in gross proceeds. PomDoctor's shares began trading on the Nasdaq Global Market under the ticker symbol "POM" on October 8, 2025. The strong after-hours performance suggests continued investor enthusiasm following the stock's positive reception during regular trading hours.

PomDoctor's successful IPO and subsequent stock performance reflect investor confidence in the company's business model, which focuses on chronic disease management and pharmaceutical services in China. As the sixth-ranked player in China's Internet hospital market based on the number of contracted doctors, PomDoctor's one-stop platform for medical services has attracted significant attention from market participants. The company's ability to connect patients with doctors and pharmaceutical products efficiently may be a key factor driving investor interest in this newly public entity.